GSK, Daewoong to face class action suit

Published: 2013-01-10 07:00:00

Updated: 2013-01-10 07:00:00

GlaxoSmithKline (GSK) will face a possible class action suit by a group of patients and consumers saying GSK colluded with Dong-A Pharm to hinder the generic sale of its anti-emetic Zofran for the past 12 years.

They also threatened to file a class action suit against Daewoong Pharm as the com...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK